Found: 323
Select item for more details and to access through your institution.
Effect of a Multifactorial Intervention on Fracture in Patients With Type 2 Diabetes: Subanalysis of the J-DOIT3 Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Internet of things‐based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial.
- Published in:
- Journal of Diabetes Investigation, 2024, v. 15, n. 9, p. 1287, doi. 10.1111/jdi.14227
- By:
- Publication type:
- Article
Insulin Resistance Syndrome in Mice Deficient in Insulin Receptor Substrate-1.
- Published in:
- Annals of the New York Academy of Sciences, 1997, v. 827, n. 1, p. 85, doi. 10.1111/j.1749-6632.1997.tb51823.x
- By:
- Publication type:
- Article
Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways.
- Published in:
- Journal of Cellular Biochemistry, 2006, v. 99, n. 1, p. 196, doi. 10.1002/jcb.20890
- By:
- Publication type:
- Article
Anagliptin increases insulin-induced skeletal muscle glucose uptake via an NO-dependent mechanism in mice.
- Published in:
- Diabetologia, 2016, v. 59, n. 11, p. 2426, doi. 10.1007/s00125-016-4071-8
- By:
- Publication type:
- Article
The sodium‐glucose co‐transporter 2 inhibitor tofogliflozin suppresses atherosclerosis through glucose lowering in ApoE‐deficient mice with streptozotocin‐induced diabetes.
- Published in:
- Pharmacology Research & Perspectives, 2022, v. 10, n. 4, p. 1, doi. 10.1002/prp2.971
- By:
- Publication type:
- Article
Incidence and prevalence of childhood-onset Type 1 diabetes in Japan: the T1D study.
- Published in:
- Diabetic Medicine, 2017, v. 34, n. 7, p. 909, doi. 10.1111/dme.13295
- By:
- Publication type:
- Article
Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2283, doi. 10.1111/dom.14829
- By:
- Publication type:
- Article
Cover Image, Volume 24, Issue 12.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 1, doi. 10.1111/dom.14114
- By:
- Publication type:
- Article
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1277, doi. 10.1111/dom.14698
- By:
- Publication type:
- Article
Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A post hoc subgroup analysis of the PIONEER 1, 3, 4 and 8 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2785, doi. 10.1111/dom.14536
- By:
- Publication type:
- Article
Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes and inadequate glycaemic control on sitagliptin.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 9, p. 2099, doi. 10.1111/dom.14448
- By:
- Publication type:
- Article
A randomized, placebo‐controlled trial to assess the efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes and inadequate glycaemic control on ipragliflozin.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1342, doi. 10.1111/dom.14346
- By:
- Publication type:
- Article
A randomized, placebo‐controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1242, doi. 10.1111/dom.14331
- By:
- Publication type:
- Article
Lower heart failure and chronic kidney disease risks associated with sodium‐glucose cotransporter‐2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, p. 19, doi. 10.1111/dom.14119
- By:
- Publication type:
- Article
Lower heart failure and chronic kidney disease risks associated with sodium‐glucose cotransporter‐2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, p. 19, doi. 10.1111/dom.14119
- By:
- Publication type:
- Article
Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 569, doi. 10.1111/dom.14254
- By:
- Publication type:
- Article
Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 75, doi. 10.1111/dom.14189
- By:
- Publication type:
- Article
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1607, doi. 10.1111/dom.14074
- By:
- Publication type:
- Article
Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo‐controlled CARMELINA® trial
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1062, doi. 10.1111/dom.13995
- By:
- Publication type:
- Article
Fast‐acting insulin aspart versus insulin aspart in the setting of insulin degludec‐treated type 1 diabetes: Efficacy and safety from a randomized double‐blind trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 12, p. 2885, doi. 10.1111/dom.13545
- By:
- Publication type:
- Article
Persistence of oral antidiabetic treatment for type 2 diabetes characterized by drug class, patient characteristics and severity of renal impairment: A Japanese database analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 12, p. 2830, doi. 10.1111/dom.13463
- By:
- Publication type:
- Article
Effect of short‐term treatment with sitagliptin or glibenclamide on daily glucose fluctuation in drug‐naïve Japanese patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 9, p. 2274, doi. 10.1111/dom.13364
- By:
- Publication type:
- Article
Biosimilar vs originator insulins: Systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 7, p. 1787, doi. 10.1111/dom.13291
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors as add‐on therapy to insulin for type 1 diabetes mellitus: Systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 7, p. 1755, doi. 10.1111/dom.13260
- By:
- Publication type:
- Article
Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group comparative study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 453, doi. 10.1111/dom.13079
- By:
- Publication type:
- Article
Long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 1, p. 77, doi. 10.1111/dom.13038
- By:
- Publication type:
- Article
Efficacy and safety of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24-week, randomized, double-blind, placebo-controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 874, doi. 10.1111/dom.12898
- By:
- Publication type:
- Article
Variations with modest effects have an important role in the genetic background of type 2 diabetes and diabetes-related traits.
- Published in:
- Journal of Human Genetics, 2012, v. 57, n. 12, p. 776, doi. 10.1038/jhg.2012.110
- By:
- Publication type:
- Article
Variations with modest effects have an important role in the genetic background of type 2 diabetes and diabetes-related traits.
- Published in:
- Journal of Human Genetics, 2012, v. 57, n. 12, p. 809, doi. 10.1038/jhg.2012.132
- By:
- Publication type:
- Article
Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity.
- Published in:
- Diabetes & Metabolism Journal, 2015, v. 39, n. 5, p. 363, doi. 10.4093/dmj.2015.39.5.363
- By:
- Publication type:
- Article
Efficacy of Self-Review of Lifestyle Behaviors with Once-Weekly Glycated Albumin Measurement in People with Type 2 Diabetes: A Randomized Pilot Study.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 7, p. 1561, doi. 10.1007/s13300-024-01599-2
- By:
- Publication type:
- Article
Publisher Correction: Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 4, p. 763, doi. 10.1007/s13300-023-01514-1
- By:
- Publication type:
- Article
Bi-weekly Glycated Albumin Measurement was Useful to Encourage Behavioral Changes in People with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 10, p. 1711, doi. 10.1007/s13300-023-01452-y
- By:
- Publication type:
- Article
Manifestation of Heart Failure and Chronic Kidney Disease are Associated with Increased Mortality Risk in Early Stages of Type 2 Diabetes Mellitus: Analysis of a Japanese Real-World Hospital Claims Database.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 2, p. 275, doi. 10.1007/s13300-021-01191-y
- By:
- Publication type:
- Article
Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 3, p. 1029, doi. 10.1007/s13300-019-0608-4
- By:
- Publication type:
- Article
Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1083, doi. 10.1007/s13300-018-0416-2
- By:
- Publication type:
- Article
Efficacy and Safety of Teneligliptin 40mg in Type 2 Diabetes: A Pooled Analysis of Two Phase III Clinical Studies.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 2, p. 623, doi. 10.1007/s13300-018-0372-x
- By:
- Publication type:
- Article
Glycemic control, mortality, secondary infection, and hypoglycemia in critically ill pediatric patients: a systematic review and network meta-analysis of randomized controlled trials.
- Published in:
- 2017
- By:
- Publication type:
- letter
Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A key role of nuclear factor Y in the refeeding response of fatty acid synthase in adipocytes.
- Published in:
- FEBS Letters, 2017, v. 591, n. 7, p. 965, doi. 10.1002/1873-3468.12620
- By:
- Publication type:
- Article
Regulation of bone resorption and sealing zone formation in osteoclasts occurs through protein kinase b-mediated microtubule stabilization.
- Published in:
- Journal of Bone & Mineral Research, 2013, v. 28, n. 5, p. 1191, doi. 10.1002/jbmr.1844
- By:
- Publication type:
- Article
Class IA phosphatidylinositol 3-kinase regulates osteoclastic bone resorption through protein kinase B-mediated vesicle transport.
- Published in:
- Journal of Bone & Mineral Research, 2012, v. 27, n. 12, p. 2464, doi. 10.1002/jbmr.1703
- By:
- Publication type:
- Article
Twin‐analysis verification: A new verification approach to alleviate pitfalls of own‐analysis verification.
- Published in:
- Quarterly Journal of the Royal Meteorological Society, 2023, v. 149, n. 752, p. 924, doi. 10.1002/qj.4441
- By:
- Publication type:
- Article
LPL/AQP7/GPD2 promotes glycerol metabolism under hypoxia and prevents cardiac dysfunction during ischemia.
- Published in:
- FASEB Journal, 2021, v. 35, n. 12, p. 1, doi. 10.1096/fj.202100882R
- By:
- Publication type:
- Article
Regulatory polymorphism in transcription factor KLF5 at the MEF2 element alters the response to angiotensin II and is associated with human hypertension.
- Published in:
- FASEB Journal, 2010, v. 24, n. 6, p. 1780, doi. 10.1096/fj.09-146589
- By:
- Publication type:
- Article
Neuronal IGF-1 resistance reduces Aβ accumulation and protects against premature death in a model of Alzheimer's disease.
- Published in:
- FASEB Journal, 2009, v. 23, n. 10, p. 3315, doi. 10.1096/fj.09-132043
- By:
- Publication type:
- Article
Roles of ATP-Sensitive K[sup+] Channels as Metabolic Sensors.
- Published in:
- Diabetes, 2004, v. 53, p. S176, doi. 10.2337/diabetes.53.suppl_3.S176
- By:
- Publication type:
- Article
Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet.
- Published in:
- 2004
- By:
- Publication type:
- journal article